Jf. Reckelhoff et al., Gender differences in development of hypertension in spontaneously hypertensive rats - Role of the renin-angiotensin system, HYPERTENSIO, 35(1), 2000, pp. 480-483
Citations number
36
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Previous data strongly support a role for androgens in promoting the gender
difference in hypertension in the spontaneously hypertensive rat(s) (SHR),
but the mechanism is not clear. Because males develop higher blood pressur
es than do females, we hypothesize that androgens may affect the renin-angi
otensin system to promote the development of hypertension in male SHR. The
present study was performed to determine the effect of converting enzyme in
hibition (CEI) on the development of hypertension in SHR. Male, female, cas
trated male, and ovariectomized (ovx) female SHR (n=10 per gender per treat
ment group) received enalapril (250 mg/L) in drinking water for 8 to 10 wee
ks. Some ovx females were also given testosterone chronically. At 17 to 19
weeks of age, 24-hour protein excretion and mean arterial pressure were mea
sured. By 13 weeks of age, male rats had higher systolic blood pressures by
tail plethysmography than did the other rats, and CEI reduced blood pressu
res to similar levels in all groups. At 17 to 19 weeks, the same trend was
found by direct measurement of mean arterial pressure. The ovx females trea
ted with. testosterone had serum testosterone and blood pressure levels sim
ilar to those found in males. CEI reduced mean arterial pressure to similar
levels in all gender groups. Untreated males and ovx females given testost
erone had significantly higher levels of urinary protein excretion than did
the other groups, and CEI had no effect on proteinuria in any of the rats.
These data suggest that the development of hypertension in SHR regardless
of sex steroids is mediated by the renin-angiotensin system. However, the d
ata further suggest that androgens promote the exacerbation of hypertension
in male SHR via a mechanism involving the renin-angiotensin system.